Ampio Competitors

AMPE Stock  USD 0.82  0.01  1.23%   
Ampio Pharm competes with Agilent Technologies, Mustang Bio, Moleculin Biotech, Seres Therapeutics, and Madrigal Pharmaceuticals; as well as few others. The company conducts business under Pharmaceuticals sector and is part of Health Care industry. Analyzing Ampio Pharm competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Ampio Pharm to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Ampio Pharm Correlation with its peers.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Ampio Pharm competition on your existing holdings.
  
The current year's Return On Capital Employed is expected to grow to -2.44. In addition to that, Return On Assets is expected to decline to -1.58. At present, Ampio Pharm's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 12.4 M, whereas Non Current Assets Total are forecasted to decline to about 283 K.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ampio Pharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.8311.00
Details
Intrinsic
Valuation
LowRealHigh
0.081.6111.78
Details
Naive
Forecast
LowNextHigh
0.010.7410.91
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ampio Pharm. Your research has to be compared to or analyzed against Ampio Pharm's peers to derive any actionable benefits. When done correctly, Ampio Pharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ampio Pharm.

Ampio Pharm Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ampio Pharm and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Ampio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ampio Pharm does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MEKA
MEMCRB
KAMCRB
MCRBMBIO
MDGLA
MCRBMBRX
  
High negative correlations   

Risk-Adjusted Indicators

There is a big difference between Ampio Stock performing well and Ampio Pharm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ampio Pharm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Ampio Pharm and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
A257 M1.2 B724 M497 M398 M460 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.4 B1.5 B
MBIO(5.4 M)(5.4 M)(5.4 M)(5.4 M)(5.4 M)(5.4 M)(12.7 M)(31.3 M)(30.7 M)(48.2 M)(62.1 M)(64.1 M)(78.9 M)(51.6 M)(54.2 M)
MBRX(365.8 K)(365.8 K)(365.8 K)(365.8 K)(365.8 K)(365.8 K)(3.9 M)(9.8 M)(11.9 M)(13.2 M)(15 M)(8.9 M)(27.4 M)(29.8 M)(28.3 M)
CLVRW(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(41.4 M)(45.6 M)(66.1 M)(41.6 M)(43.7 M)
MCRB(3.1 M)(3.1 M)(3.1 M)(6.1 M)(16.7 M)(54.8 M)(91.6 M)(89.4 M)(98.9 M)(64.2 M)(86.5 M)(61.5 M)(253.8 M)(113.7 M)(119.4 M)
MDGL(381 K)(47.4 M)(62.8 M)(90.2 M)(86.2 M)(68.7 M)(26.4 M)(31.2 M)(32.8 M)(72.8 M)(197.4 M)(241.1 M)(299.3 M)(373.6 M)(354.9 M)
EQ(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(13.2 M)(25.6 M)(29.8 M)(39 M)(107.7 M)(13.3 M)(14 M)
KA(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(13.9 M)(12 M)(63.1 M)(14.1 M)(14.8 M)
ME(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(289.3 M)(183.4 M)(217.5 M)(311.7 M)(280.5 M)(294.5 M)

Ampio Pharm and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Ampio Pharm financial statement analysis. It represents the amount of money remaining after all of Ampio Pharm operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Ampio Pharm Competitive Analysis

The better you understand Ampio Pharm competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ampio Pharm's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ampio Pharm's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMPEAMBIOMBRXCLVRWMCRBMDGLEQKAME
 1.23 
 0.82 
Ampio
 2.05 
 147.37 
Agilent
 1.08 
 0.94 
Mustang
 18.38 
 5.54 
Moleculin
 2.94 
 0.04 
Clever
 4.00 
 0.78 
Seres
 4.52 
 258.81 
Madrigal
 15.57 
 2.06 
Equillium
 5.45 
 0.52 
Kineta
 4.08 
 0.51 
23Andme
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Ampio Pharm Competition Performance Charts

Five steps to successful analysis of Ampio Pharm Competition

Ampio Pharm's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ampio Pharm in relation to its competition. Ampio Pharm's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ampio Pharm in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ampio Pharm's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ampio Pharm, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ampio Pharm position

In addition to having Ampio Pharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Ampio Pharm is a strong investment it is important to analyze Ampio Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ampio Pharm's future performance. For an informed investment choice regarding Ampio Stock, refer to the following important reports:
Check out Ampio Pharm Correlation with its peers.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Ampio Stock analysis

When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Ampio Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ampio Pharm. If investors know Ampio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ampio Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.70)
Return On Assets
(0.47)
Return On Equity
(0.92)
The market value of Ampio Pharm is measured differently than its book value, which is the value of Ampio that is recorded on the company's balance sheet. Investors also form their own opinion of Ampio Pharm's value that differs from its market value or its book value, called intrinsic value, which is Ampio Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ampio Pharm's market value can be influenced by many factors that don't directly affect Ampio Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ampio Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ampio Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ampio Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.